News|Oncology Information Management Systems (OIMS)| October 22, 2021

RaySearch Laboratories AB will be showcasing the latest oncology software innovations atASTRO 2021, to be held in Chicago, October 24-27

 The latest versions of RayStation (11A) and RayCare (5A) were released in May 2021. A new feature in the RayStation release is dose planning for Accuray’s CyberKnife system for radiosurgery and stereotactic body radiation therapy (SBRT).

October 22, 2021 — The latest versions ofRayStation (11A)andRayCare (5A)were released in May 2021. A new feature in the RayStation release is dose planning for Accuray’sCyberKnifesystem for radiosurgery and stereotactic body radiation therapy (SBRT). RayStation provides support for optimization with the three different types of collimations – fixed cones, Iris Variable Aperture and Incise Multileaf Collimator – as well as all CyberKnife techniques for Synchrony real-time motion synchronization. The release also includes innovations in organ segmentation using deep learning with model support for organs in the head and neck, thorax, and pelvis regions.

Further, the exhibition will feature brachytherapy dose planning with automatic reconstruction of treatment channels combined with powerful dwell time optimization, ultra-fast Monte Carlo dose calculation for protons, multicriteria optimization (MCO), Plan Explorer and many other advanced features of RayStation.

The latest RayStation version also provides expanded integration with the oncology information system RayCare and the treatment control systemRayCommand,这使得临床工作流程更加顺畅。

In RayCare 5A several features have been added to promote clinical efficiency and improve safety by reducing the number of manual routine tasks. The new features include support for managing radiation therapy prescriptions and a new whiteboard that provides an overview of patient treatments including information on readiness for treatment.

RayIntelligence automatically extracts patient and treatment data from RayStation for visualization and analysis of patient populations. The first version of RayIntelligence was released in December 2020, and atASTRO 2021the latest version (1C), which has enhanced functionality for analyzing and comparing treatment plans for patient populations, will be presented.

在展台上,Accuray和RaySearch将联合展示Radixact治疗交付系统的在线自适应放疗流畅高效的工作流程预览。通过考虑患者的当前情况,利用高质量的ClearRT图像,实时目标跟踪和高效、平滑的自适应重新规划框架的RayStation和RayCare,提供每个特定的患者每天的最佳治疗是启用的。在完全自动化的自适应工作流中,日常计划是基于日常图像和利用RaySearch的高级功能,如深度学习分割和基于gpu的剂量计算进行优化。

During ASTRO, on Oct. 23, RaySearch and Accuray are also hosting an online adaptive preview at Marriott Marquis. Read more and sign uphere.

Related Content

Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News|Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

TimeAugust 10, 2022
arrow
Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx).
News|Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

TimeAugust 09, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News|2022世界杯篮球预选赛赛程

2022年8月8日-美国食品和药物管理局批准了Enhertu (fam-曲妥珠单抗-德鲁克特康-nxki),一种IV…

TimeAugust 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News|Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

TimeAugust 08, 2022
arrow
David Gerber, MD
News|Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

TimeAugust 08, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News|Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

TimeAugust 05, 2022
arrow
Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot
News|Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

TimeAugust 04, 2022
arrow
News|世界杯2022赛程时间表

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

TimeAugust 03, 2022
arrow
The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to grow to $5.4 Bn by 2032, at a CAGR of 7.8% from 2022 to 2032.
Feature|Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

TimeAugust 02, 2022
arrow
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer, the leading cancer killer of women and men.
Feature|Lung Imaging

August 1, 2022 — In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources ...

TimeAugust 01, 2022
arrow
Subscribe Now